Linked Life Data

18603779

Source:http://linkedlifedata.com/resource/pubmed/id/18603779

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-7-23
pubmed:abstractText
We determined the effects of yolk water-soluble protein (YSP) on bone resorption. YSP potently suppressed osteoclastogenesis from bone marrow-derived precursor cells driven by tumor necrosis factor-alpha (TNF-alpha). YSP (200 microg/ml) abolished the formation of tartarate-resistant acid phosphatase (TRAP)-positive osteoclasts. Furthermore, TNF-alpha induced TRAP activity was greatly inhibited by YSP (100 microg/ml) treatment. Our results suggest that YSP has therapeutic potential for bone-erosive diseases.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1347-6947
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1929-31
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Inhibitory effects of egg yolk soluble protein on bone resorption.
pubmed:affiliation
Department of Food and Biotechnology, Hanseo University, Seosan, Chungnam, South Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't